Skip to content

BIL vs SHV: returns, risk and drawdowns compared

SPDR Bloomberg 1-3 Month T-Bill ETF against iShares Short Treasury Bond ETF, over the same 19 years (June 2007 to October 2026) with dividends reinvested.

Data updated October 2026

BIL

SPDR Bloomberg 1-3 Month T-Bill ETF

10,000 became

13,733

A year on average
+1.6%
Annual volatility
0.7%
Deepest fall
−0.4%
Worst month
−0.1%

SHV

iShares Short Treasury Bond ETF

10,000 became

13,466

A year on average
+1.5%
Annual volatility
0.6%
Deepest fall
−0.3%
Worst month
−0.1%

BIL came out ahead by 0.1 percentage points a year from June 2007 to October 2026. BIL swung more (0.7% against 0.6% a year). The correlation of monthly returns was 0.86: they usually moved together.

Growth of 10,000: BIL vs SHV

10k12k200820152022
BIL — SPDR Bloomberg 1-3 Month T-Bill ETFSHV — iShares Short Treasury Bond ETF

Who was ahead, and when

The gap between the two over the previous three years, at each month-end. Above zero BIL had returned more, below zero SHV. BIL was ahead in 40% of the 198 three-year periods.

0+0.5 pt200820152022

Annualised 3-year return of BIL minus that of SHV, in percentage points a year.

Falls from the previous high

0%0%0%200820152022
BILSHV

Month-end values. Deepest fall: BIL −0.4%, SHV −0.3%.

All the figures

BILSHV
Annual return (CAGR)+1.6%+1.5%
Total return+37%+35%
Annual volatility0.7%0.6%
Deepest fall (month-end)−0.4%−0.3%
Worst month−0.1%−0.1%
Best month+0.9%+0.9%
Positive months62%71%
Best year2024: +5.2%2024: +5.1%
Worst year2015: −0.1%2021: −0.1%
1-year return+3.7%+3.6%
5 years, a year+3.7%+3.6%
10 years, a year+2.4%+2.4%
Trading currencyUSDUSD

First nine rows: the same 233 months for both funds. Trailing returns: to each fund’s last close.

Year by year

2025
BIL+4.2%
SHV+4.2%
2024
BIL+5.2%
SHV+5.1%
2023
BIL+5.0%
SHV+5.0%
2022
BIL+1.4%
SHV+0.9%
2021
BIL−0.1%
SHV−0.1%
2020
BIL+0.4%
SHV+0.8%
2019
BIL+2.0%
SHV+2.4%
2018
BIL+1.7%
SHV+1.7%
2017
BIL+1.2%
SHV+0.7%
2016
BIL+0.2%
SHV+0.4%
2015
BIL−0.1%
SHV0.0%
2014
BIL−0.1%
SHV0.0%
2013
BIL−0.1%
SHV0.0%
2012
BIL−0.0%
SHV+0.0%
2011
BIL−0.0%
SHV+0.1%
2010
BIL−0.0%
SHV+0.1%
2009
BIL+0.4%
SHV+0.2%
2008
BIL+3.2%
SHV+2.8%

Full calendar years both funds were trading. The higher of the two each year is in bold.

Holding both: half BIL, half SHV

BIL aloneSHV alone50/50
A year on average+1.6%+1.5%+1.6%
Annual volatility0.7%0.6%0.6%
Deepest fall (month-end)−0.4%−0.3%−0.2%
Worst month−0.1%−0.1%−0.1%

Because the two did not always move together, the mix swung less than the average of the two (0.6% against 0.6%). Rebalanced to 50/50 every month, before costs.

Questions

Which has returned more, BIL or SHV?

From June 2007 to October 2026, BIL returned +1.6% a year and SHV +1.5% a year, with dividends reinvested. Over rolling 3-year periods BIL did better in 40% of cases. Past returns do not predict future returns.

Which is riskier, BIL or SHV?

Over the same months annual volatility was 0.7% for BIL and 0.6% for SHV; the deepest fall from a month-end high was 0.4% and 0.3%, and the worst single month −0.1% and −0.1%.

How correlated are BIL and SHV?

The correlation of their monthly returns was 0.86: they usually moved together. Combining them has historically given some diversification.

What about holding both BIL and SHV?

Half in each, rebalanced every month, returned +1.6% a year over the same period, with 0.6% annual volatility and a deepest month-end fall of 0.2%.

More comparisons

How the figures are calculated

Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.

The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.

Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.